Association of X-box binding protein 1 (XBP1) genotype with morning cortisol and 1-year clinical course after a major depressive episode

International Journal of Neuropsychopharmacology

Volumn 12, Issue 2, 2009, Pages 281-283

  Grunebaum, Michael F ^a   Galfalvy, Hanga C ^a   Huang, Yung Yu ^a   Cooper, Thomas B ^a   Burke, Ainsley K ^a   Agnello, Melissa ^a   Oquendo, Maria A ^a   Mann, J John ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Cortisol; Endoplasmic reticulum stress; Genetics; Major depressive disorder; Unfolded protein response

Indexed keywords

ANTIDEPRESSANT AGENT; HYDROCORTISONE; X BOX BINDING PROTEIN 1; DNA BINDING PROTEIN; REGULATORY FACTOR X TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR;

ADULT; ARTICLE; CELL STRESS; DISEASE COURSE; FEMALE; FOLLOW UP; GENE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSPECTIVE STUDY; XBP1 GENE; BLOOD; CIRCADIAN RHYTHM; GENETICS; METHODOLOGY; NONPARAMETRIC TEST; RADIOIMMUNOASSAY; SURVIVAL; TIME;

ADULT; CIRCADIAN RHYTHM; DEPRESSIVE DISORDER, MAJOR; DNA-BINDING PROTEINS; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; HYDROCORTISONE; MALE; POLYMORPHISM, GENETIC; RADIOIMMUNOASSAY; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TIME FACTORS; TRANSCRIPTION FACTORS;

EID: 67049116495     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145708009863     Document Type: Article

References (11)

1. Belmaker RH, Agam G (2008). Major depressive disorder. New England Journal of Medicine 358, 55-68.
2. Cichon S, Buervenich S, Kirov G, Nirmala A, Dimitrova A, Green E, Schumacher J, Klopp N, Becker T, Ohlraun S, et al. (2004). Lack of support for a genetic association of the XBP1 promoter polymorphism with bipolar disorder in probands of European origin. Nature Genetics 36, 783-784.
3. Hou SJ, Feng-Chang Y, Cheng CY, Tsai SJ, Hong CJ (2004). X-box binding protein 1 (XBP1) C-116G polymorphisms in bipolar disorders and age of onset. Neuroscience Letters 367, 232-234.
4. Huang YY, Oquendo MA, Friedman JM, Greenhill LL, Brodsky B, Malone KM, Khait V, Mann JJ (2003). Substance abuse disorder and major depression are associated with the human 5-HT1B receptor gene (HTR1B) G861C polymorphism. Neuropsychopharmacology 28, 163-169.
5. Kakiuchi C, Iwamoto K, Ishiwata M, Bundo M, Kasahara T, Kusumi I, Tsujita T, Okazaki Y, Nanko S, Kunugi H, et al. (2003). Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder. Nature Genetics 35, 171-174.
6. Kaufman RJ (2002). Orchestrating the unfolded protein response in health and disease. Journal of Clinical Investigation 110, 1389-1398.
7. Lin PI, Vance JM, Pericak-Vance MA, Martin ER (2007). No gene is an island: the flip-flop phenomenon. American Journal of Human Genetics 80, 531-538.
8. Lindholm D, Wootz H, Korhonen L (2006). ER stress and neurodegenerative diseases. Cell Death and Differentiation 13, 385-392.
9. So J, Warsh JJ, Li PP (2007). Impaired endoplasmic reticulum stress response in B-lymphoblasts from patients with bipolar-I disorder. Biological Psychiatry 62, 141-147.
10. Toda H, Suzuki G, Nibuya M, Shioda K, Nishijima K, Wakizono T, Kanda Y, Watanabe Y, Shimizu K, Nomura S (2006). Behavioral stress and activated serotonergic neurotransmission induce XBP-1 splicing in the rat brain. Brain Research 1112, 26-32.
11. Yoshida H, Matsui T, Yamamoto A, Okada T, Mori K (2001). XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107, 881-891.